{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:20:17Z","timestamp":1783549217347,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic inflammation predisposes to poor bone health. Women with polycystic ovary syndrome (PCOS) experience androgen excess, ovulatory disturbances, insulin resistance, abdominal adiposity and chronic inflammation. Our objective was to investigate the relationships among bone health parameters, chronic subclinical inflammation and anthropometric measures in premenopausal women with and without PCOS. In 61 premenopausal women, 22 women with PCOS and 39 controls, we assessed bone parameters (total hip bone mineral density [BMD] by dual-energy X-ray absorptiometry and radius strength-strain index [SSI] by peripheral quantitative computed tomography), inflammation (C-reactive protein\/albumin), oxidative stress (leukocyte telomere length, urinary 8-hydroxydeoxyguanosine); hemoglobin A1c; anthropometric measures (body mass index, waist-to-height ratio, cross-sectional muscle area). A diagnosis of PCOS negatively predicted (beta\u2009=\u2009\u22120.251, <jats:italic>p<\/jats:italic>\u2009=\u20090.022) hip BMD in a regression model including weight. In women with PCOS, inflammation, which was predicted by increased waist-to-height ratio and current use of oral contraceptives, attenuated the positive influences of increased weight and muscle mass on bone strength and was inversely associated with radial SSI (R<jats:sup>2<\/jats:sup>\u2009=\u20090.25, <jats:italic>p<\/jats:italic>\u2009=\u20090.018). In conclusion, chronic subclinical inflammation may negatively impact bone physiology in women with PCOS. Strategies focused on reducing abdominal adiposity and avoiding medications that increase inflammation may counter this effect.<\/jats:p>","DOI":"10.1038\/s41598-017-03685-x","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T14:35:28Z","timestamp":1496846128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll"],"prefix":"10.1038","volume":"7","author":[{"given":"Shirin","family":"Kalyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-6837","authenticated-orcid":false,"given":"Millan S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kingwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne C. F.","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerilynn C.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser, B. C. et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. \n                           97, 28\u201338.e25 (2012).","journal-title":"Fertil. Steril."},{"key":"3685_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0889-8529(05)70075-X","volume":"28","author":"RS Legro","year":"1999","unstructured":"Legro, R. S. Polycystic ovary syndrome. Phenotype to genotype. Endocrinol. Metab. Clin. North Am. \n                           28, 379\u2013396 (1999).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3685_CR3","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz, R. et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. \n                           89, 2745\u20132749 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3685_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S1472-6483(10)61644-6","volume":"8","author":"R Azziz","year":"2004","unstructured":"Azziz, R. PCOS: a diagnostic challenge. Reprod. Biomed. Online. \n                           8, 644\u2013648 (2004).","journal-title":"Reprod. Biomed. Online."},{"key":"3685_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1586\/eem.12.73","volume":"8","author":"CN Wijeyaratne","year":"2013","unstructured":"Wijeyaratne, C. N., Udayangani, S. A. D. & Balen, A. H. Ethnic-specific Polycystic Ovary Syndrome. Expert Review of Endocrinology and Metabolism \n                           8, 71\u201379 (2013).","journal-title":"Expert Review of Endocrinology and Metabolism"},{"key":"3685_CR6","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/humrep\/deq149","volume":"25","author":"D Kassanos","year":"2010","unstructured":"Kassanos, D. et al. Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study. Hum. Reprod. \n                           25, 2107\u20132114 (2010).","journal-title":"Hum. Reprod."},{"key":"3685_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/jbmr.2737","volume":"31","author":"KH Rubin","year":"2016","unstructured":"Rubin, K. H., Glintborg, D., Nybo, M., Andersen, M. & Abrahamsen, B. Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study. J. Bone Miner. Res. \n                           31, 709\u2013717 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"3685_CR8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","volume":"16","author":"JM Koh","year":"2005","unstructured":"Koh, J. M. et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos. Int. \n                           16, 1263\u20131271 (2005).","journal-title":"Osteoporos. Int."},{"key":"3685_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11914-012-0104-5","volume":"10","author":"T Braun","year":"2012","unstructured":"Braun, T. & Schett, G. Pathways for bone loss in inflammatory disease. Curr. Osteoporos Rep \n                           10, 101\u2013108 (2012).","journal-title":"Curr. Osteoporos Rep"},{"key":"3685_CR10","first-page":"305","volume":"332","author":"SC Manolagas","year":"1995","unstructured":"Manolagas, S. C. & Jilka, R. L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med \n                           332, 305\u2013311 (1995).","journal-title":"Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med"},{"key":"3685_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"SC Manolagas","year":"2010","unstructured":"Manolagas, S. C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. \n                           31, 266\u2013300 (2010).","journal-title":"Endocr. Rev."},{"key":"3685_CR12","doi-asserted-by":"crossref","unstructured":"Ojeda-Ojeda, M., Murri, M., Insenser, M. & Escobar-Morreale, H. F. Mediators of Low-Grade Chronic Inflammation in Polycystic Ovary Syndrome (PCOS). Curr. Pharm. Des (2013).","DOI":"10.2174\/1381612811319320012"},{"key":"3685_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"HF Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale, H. F., Luque-Ramirez, M. & Gonzalez, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil. Steril. \n                           95, 1048\u201358.e1-2 (2011).","journal-title":"Fertil. Steril."},{"key":"3685_CR14","first-page":"107","volume":"58","author":"SA Blair","year":"2013","unstructured":"Blair, S. A. et al. Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome. J. Reprod. Med. \n                           58, 107\u2013114 (2013).","journal-title":"J. Reprod. Med."},{"key":"3685_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1089\/jwh.2009.1751","volume":"19","author":"E Battistella","year":"2010","unstructured":"Battistella, E., Kalyan, S. & Prior, J. C. Evaluation of methods and costs associated with recruiting healthy women volunteers to a study of ovulation. J. Womens Health. (Larchmt) \n                           19, 1519\u20131524 (2010).","journal-title":"J. Womens Health. (Larchmt)"},{"key":"3685_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/08958370701401418","volume":"19","author":"B Isik","year":"2007","unstructured":"Isik, B., Ceylan, A. & Isik, R. Oxidative stress in smokers and non-smokers. Inhal. Toxicol. \n                           19, 767\u2013769 (2007).","journal-title":"Inhal. Toxicol."},{"key":"3685_CR17","doi-asserted-by":"publisher","unstructured":"Shiels, M. S. et al. Cigarette smoking and variations in systemic immune and inflammation markers. J. Natl. Cancer Inst. 106, doi:10.1093\/jnci\/dju294. Print 2014 Nov (2014).","DOI":"10.1093\/jnci\/dju294"},{"key":"3685_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. \n                           91, 456\u2013488 (2009).","journal-title":"Fertil. Steril."},{"key":"3685_CR19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bone.2006.02.057","volume":"39","author":"H Macdonald","year":"2006","unstructured":"Macdonald, H., Kontulainen, S., Petit, M., Janssen, P. & McKay, H. Bone strength and its determinants in pre- and early pubertal boys and girls. Bone \n                           39, 598\u2013608 (2006).","journal-title":"Bone"},{"key":"3685_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1139\/h11-065","volume":"36","author":"AL Lorbergs","year":"2011","unstructured":"Lorbergs, A. L., Farthing, J. P., Baxter-Jones, A. D. & Kontulainen, S. A. Forearm muscle size, strength, force, and power in relation to pQCT-derived bone strength at the radius in adults. Appl. Physiol. Nutr. Metab. \n                           36, 618\u2013625 (2011).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"3685_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF01626606","volume":"5","author":"O Louis","year":"1995","unstructured":"Louis, O., Willnecker, J., Soykens, S., Van den Winkel, P. & Osteaux, M. Cortical thickness assessed by peripheral quantitative computed tomography: accuracy evaluated on radius specimens. Osteoporos. Int. \n                           5, 446\u2013449 (1995).","journal-title":"Osteoporos. Int."},{"key":"3685_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1566524053586545","volume":"5","author":"T von Zglinicki","year":"2005","unstructured":"von Zglinicki, T. & Martin-Ruiz, C. M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. \n                           5, 197\u2013203 (2005).","journal-title":"Curr. Mol. Med."},{"key":"3685_CR23","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","volume":"37","author":"RM Cawthon","year":"2009","unstructured":"Cawthon, R. M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res \n                           37, e21 (2009).","journal-title":"Nucleic Acids Res"},{"key":"3685_CR24","doi-asserted-by":"publisher","first-page":"e57787","DOI":"10.1371\/journal.pone.0057787","volume":"8","author":"DL Zanet","year":"2013","unstructured":"Zanet, D. L. et al. Blood and dried blood spot telomere length measurement by qPCR: assay considerations. PLoS One \n                           8, e57787 (2013).","journal-title":"PLoS One"},{"key":"3685_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1592\/phco.30.5.442","volume":"30","author":"S Kalyan","year":"2010","unstructured":"Kalyan, S., Hitchcock, C. L., Sirrs, S., Pudek, M. & Prior, J. C. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy. Pharmacotherapy \n                           30, 442\u2013452 (2010).","journal-title":"Pharmacotherapy"},{"key":"3685_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell, M., Gunn, P. & Gibson, S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes. Rev \n                           13, 275\u2013286 (2012).","journal-title":"Obes. Rev"},{"key":"3685_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2010.02.017","volume":"106","author":"GC Brooks","year":"2010","unstructured":"Brooks, G. C., Blaha, M. J. & Blumenthal, R. S. Relation of C-reactive protein to abdominal adiposity. Am. J. Cardiol. \n                           106, 56\u201361 (2010).","journal-title":"Am. J. Cardiol."},{"key":"3685_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy, R. & Cooper, M. S. Bone loss in inflammatory disorders. J. Endocrinol. \n                           201, 309\u2013320 (2009).","journal-title":"J. Endocrinol."},{"key":"3685_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrendo.2010.190","volume":"6","author":"G Schett","year":"2010","unstructured":"Schett, G. & David, J. P. The multiple faces of autoimmune-mediated bone loss. Nat. Rev. Endocrinol \n                           6, 698\u2013706 (2010).","journal-title":"Nat. Rev. Endocrinol"},{"key":"3685_CR30","doi-asserted-by":"publisher","first-page":"615486","DOI":"10.1155\/2015\/615486","volume":"2015","author":"SA Hienz","year":"2015","unstructured":"Hienz, S. A., Paliwal, S. & Ivanovski, S. Mechanisms of Bone Resorption in Periodontitis. J. Immunol. Res. \n                           2015, 615486 (2015).","journal-title":"J. Immunol. Res."},{"issue":"Suppl 4","key":"3685_CR31","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0015-0282(02)02968-0","volume":"77","author":"M Notelovitz","year":"2002","unstructured":"Notelovitz, M. Androgen effects on bone and muscle. Fertil. Steril. \n                           77(Suppl 4), S34\u201341 (2002).","journal-title":"Fertil. Steril."},{"key":"3685_CR32","first-page":"445","volume":"98","author":"T Douchi","year":"2001","unstructured":"Douchi, T. et al. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet. Gynecol. \n                           98, 445\u2013449 (2001).","journal-title":"Obstet. Gynecol."},{"key":"3685_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1359\/jbmr.090318","volume":"24","author":"JL Sanders","year":"2009","unstructured":"Sanders, J. L. et al. Leukocyte Telomere Length Is Not Associated With BMD, Osteoporosis, or Fracture in Older Adults: Results From the Health, Aging and Body Composition Study. J. Bone Miner. Res. \n                           24, 1531\u20131536 (2009).","journal-title":"J. Bone Miner. Res."},{"key":"3685_CR34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00198-007-0357-5","volume":"18","author":"AM Valdes","year":"2007","unstructured":"Valdes, A. M. et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos. Int. \n                           18, 1203\u20131210 (2007).","journal-title":"Osteoporos. Int."},{"key":"3685_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exger.2015.04.004","volume":"66","author":"BR Nielsen","year":"2015","unstructured":"Nielsen, B. R. et al. Association between leukocyte telomere length and bone mineral density in women 25\u201393 years of age. Exp. Gerontol. \n                           66, 25\u201331 (2015).","journal-title":"Exp. Gerontol."},{"key":"3685_CR36","doi-asserted-by":"publisher","first-page":"7067984","DOI":"10.1155\/2016\/7067984","volume":"2016","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses. Dis. Markers \n                           2016, 7067984 (2016).","journal-title":"Dis. Markers"},{"key":"3685_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2265.2012.04466.x","volume":"78","author":"A Harmanci","year":"2013","unstructured":"Harmanci, A., Cinar, N., Bayraktar, M. & Yildiz, B. O. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clin. Endocrinol. (Oxf) \n                           78, 120\u2013125 (2013).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"3685_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s12020-015-0625-7","volume":"50","author":"LJ Moran","year":"2015","unstructured":"Moran, L. J. et al. Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome. Endocrine \n                           50, 811\u2013815 (2015).","journal-title":"Endocrine"},{"key":"3685_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2265.2012.04378.x","volume":"77","author":"J Schmidt","year":"2012","unstructured":"Schmidt, J., Dahlgren, E., Brannstrom, M. & Landin-Wilhelmsen, K. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study. Clin. Endocrinol. (Oxf) \n                           77, 207\u2013214 (2012).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"3685_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i3.30","volume":"20","author":"S Kalyan","year":"2010","unstructured":"Kalyan, S. & Prior, J. C. Bone changes and fracture related to menstrual cycles and ovulation. Crit. Rev. Eukaryot. Gene Expr. \n                           20, 213\u2013233 (2010).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"3685_CR41","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly, C. C. et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. \n                           86, 2453\u20132455 (2001).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03685-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03685-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03685-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:28:23Z","timestamp":1671773303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03685-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03685-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]},"assertion":[{"value":"12 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing financial interests related to this study to declare. Unrelated to the contents of this study, S.K. holds the position of Director of Scientific Innovation at Qu Biologics (Vancouver-based biotechnology company).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3432"}}